Jennifer has a wealth of experience as a patent attorney, spending time as a coordinator of global IP portfolios, strategic advisor, EPO opposition specialist, and drafter and prosecutor of patent applications in the engineering and physics fields.
She is particularly strong in the fields of mechanical devices and subsea technology (e.g. pipelines, cable protection, vehicles, vessels), medical devices (e.g. wound dressings, vacuum therapy apparatus, retinal treatment devices, waste disposal) and apparatus incorporating aspects of physics or electrochemistry. She is also expanding her knowledge into the wind energy sector and renewables in general.
Jennifer appears frequently at the EPO in Munich and The Hague to attend opposition and appeal hearings. She enjoys a debate and believes that the scrutiny and detail of opposition proceedings is the best way to continually hone your patent skills.
Jennifer is also a member of the firm's Asia business development team as Japan coordinator, working to review and increase business with Japan and foster our relationship with Japanese firms. Having started her IP career at a Japanese patent firm, she gained invaluable insight into the way different businesses and clients operate, and an appreciation of cultural diversity.
Honours degree in Mining and mineral engineering
Electrochemical gas sensors
"Jennifer Uno attracts effusive feedback: “Jenny knows our needs very well and surprises us by advancing on solutions for our IP matters at the soonest opportunity. She is always extremely easy to reach, will make time to know more about the company, and will not miss a small gap left in the prosecution of your files or in your new invention. Her creative disposition when it comes to ideas and solutions on how to accommodate our needs or demands are difficult to find elsewhere.”"
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.